1086375-50-9

Basic information

• Product Name: PYRAZOLO[1,5-A]PYRIMIDINE-5-CARBOXYLICACID
• Synonyms: PYRAZOLO[1,5-A]PYRIMIDINE-5-CARBOXYLICACID
• CAS NO: 1086375-50-9
• Molecular Formula: C₇H₅N₃O₂
• Molecular Weight: 163
• Product Categories: Carboxylic Acids;Carboxylic Acids;Fused Ring Systems
• Mol File: 1086375-50-9.mol
• Article Data: 5

Chemical Properties

• Appearance: Yellow/Powder
• Density: 1.58±0.1 g/cm3(Predicted)
• Storage Temp.: -20°C Freezer, Under inert atmosphere
• Solubility: DMSO (Slightly), Methanol (Slightly, Sonicated)
• PKA: -5.95±0.41(Predicted)
• CAS DataBase Reference: PYRAZOLO[1,5-A]PYRIMIDINE-5-CARBOXYLICACID(CAS DataBase Reference)
• NIST Chemistry Reference: PYRAZOLO[1,5-A]PYRIMIDINE-5-CARBOXYLICACID(1086375-50-9)
• EPA Substance Registry System: PYRAZOLO[1,5-A]PYRIMIDINE-5-CARBOXYLICACID(1086375-50-9)

Safety Data

• Hazardous Substances Data: 1086375-50-9(Hazardous Substances Data)

Usage

General Description

PYRAZOLO[1,5-A]PYRIMIDINE-5-CARBOXYLICACID is a chemical compound with the molecular formula C7H5N3O2. It is a pyrazolo[1,5-a]pyrimidine derivative, which belongs to the class of carboxylic acids. PYRAZOLO[1,5-A]PYRIMIDINE-5-CARBOXYLICACID is known for its potential pharmaceutical applications, particularly in the development of pharmaceutical drugs. It exhibits a wide range of biological activities, including anti-inflammatory, antiproliferative, and potential anticancer properties. Additionally, it has shown promising results in the treatment of a variety of diseases, making it a valuable compound for medicinal and pharmaceutical research. Further studies and research are being conducted to explore its full potential and possible applications in the pharmaceutical industry.

Upstream product

• 1453176-67-4 pyrazolo[1,5-a]pyrimidine-5-carboxylic acid methyl ester 
• 29274-24-6 5-chloropyrazolo[1,5-a]pyrimidine 
• 29274-22-4 4H,5H-pyrazolo[1,5-a]pyrimidine-5-one 

Relevant articles and documents

AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

AMIDO-BENZYL SULFONE AND SULFONAMIDE DERIVATIVES

Disclosed are certain amido-benzyl sulfone and sulfonamide compounds, pharmaceutical compositions comprising such compounds, land methods of treatment using such compounds.

ALKYL-AND DI-SUBSTITUTED AMIDO-BENZYL SULFONAMIDE DERIVATIVES

The present invention relates to certain alkyl- and di-substituted amido-benzyl sulfonamide compounds, pharmaceutical compositions comprising such compounds, and to methods of treatment of NAMPT-mediated disorders, such as diabetes, rheumatoid arthritis,